110 related articles for article (PubMed ID: 3617000)
1. [Information centers on undesirable effects of drugs: also on alerting function].
Bégaud B; Péré JC; Tubert P; Barat C; Haramburu F; Albin H
Therapie; 1987; 42(2):231-7. PubMed ID: 3617000
[No Abstract] [Full Text] [Related]
2. [Advantages of a microcomputer system in researching duplicated reports].
Biour M; Wagniart F; Jablonka J; Hamel JD; Weissenburger J; Cheymol G
Therapie; 1986; 41(5):383-4. PubMed ID: 3810530
[No Abstract] [Full Text] [Related]
3. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
Hamel JD; Biour M; Cheymol G
Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
[No Abstract] [Full Text] [Related]
4. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
Pham E; Ventre JJ; Saddier P; Descotes J; Evreux JC
Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
[No Abstract] [Full Text] [Related]
5. [Drug nephrotoxicity. A microcomputerized databank of renal involvement and responsible "nephrotox" drugs].
Hamel JD; Biour M; Cheymol G
Therapie; 1988 May; 43(3):211-7. PubMed ID: 3420569
[No Abstract] [Full Text] [Related]
6. Statewide test of a new postmarketing drug surveillance system.
Fisher S; Bryant SG; Solovitz BL; Kluge RM
Tex Med; 1987 Aug; 83(8):59-62. PubMed ID: 3660262
[No Abstract] [Full Text] [Related]
7. Critical reflection on the collection and evaluation of adverse drug reaction data.
Venulet J
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S48-53. PubMed ID: 3842691
[No Abstract] [Full Text] [Related]
8. [Drug monitoring].
Royer RJ
Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
[No Abstract] [Full Text] [Related]
9. [Comparative organization of drug monitoring in France and 7 European countries].
Vaissere J; de Cremiers F; Auriche M; Juillet Y
Therapie; 1986; 41(5):369-74. PubMed ID: 3810527
[No Abstract] [Full Text] [Related]
10. Rhode Island physicians' recognition and reporting of adverse drug reactions.
Scott HD; Rosenbaum SE; Waters WJ; Colt AM; Andrews LG; Juergens JP; Faich GA
R I Med J (1976); 1987 Jul; 70(7):311-6. PubMed ID: 3476980
[No Abstract] [Full Text] [Related]
11. [Drug surveillance as seen by the general practitioner. Apropos of a survey of 4175 physicians].
Begaud B; Haramburu F; Péré JC; Delmas N; Lorson B; Albin H
Therapie; 1984; 39(5):453-7. PubMed ID: 6506000
[No Abstract] [Full Text] [Related]
12. [Responsibility of the pharmaceutical industry toward the first undesirable effects of new products].
Juillet Y; de Cremiers F
Therapie; 1988; 43(5):385-8. PubMed ID: 3227498
[No Abstract] [Full Text] [Related]
13. Measuring adverse drug reactions in a postmarketing surveillance system.
Fisher S; Bryant SG; Kluge RM
Psychopharmacol Bull; 1986; 22(1):272-7. PubMed ID: 3726073
[No Abstract] [Full Text] [Related]
14. [How to assess the risk of drugs?].
Roujeau JC
Ann Dermatol Venereol; 1998 Oct; 125(10):673-5. PubMed ID: 9835953
[No Abstract] [Full Text] [Related]
15. [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].
Bégaud B; Evreux JC; Jouglard J; Lagier G
Therapie; 1985; 40(2):111-8. PubMed ID: 4002188
[No Abstract] [Full Text] [Related]
16. [Post-marketing surveillance of drugs: epidemiologic approach].
Stanulović M; Jakovljević V; Sabo A
Med Pregl; 1987; 40(11-12):573-7. PubMed ID: 3331415
[No Abstract] [Full Text] [Related]
17. Monitoring adverse drug reactions in the postmarketing phase.
Hoigné R; Hottinger S
Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
[No Abstract] [Full Text] [Related]
18. [Mandatory report of adverse effects of drugs: has the order modified the spontaneous notification?].
Haramburu F; Pere JC; Begaud B; Albin H
Therapie; 1988; 43(6):493-6. PubMed ID: 3227516
[No Abstract] [Full Text] [Related]
19. Advantages of adverse-effect reporting by patients.
Prescrire Int; 2011 Mar; 20(114):70. PubMed ID: 21648228
[No Abstract] [Full Text] [Related]
20. [Seventh French Drug Surveillance Seminar. Caen, 21-22 November 1985].
Therapie; 1986; 41(5):323-84. PubMed ID: 3810518
[No Abstract] [Full Text] [Related]
[Next] [New Search]